These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3875948)

  • 1. [Clinico-immunological characteristics of Kaposi's disease].
    Shaposhnikov OK; Karachunova TN
    Vestn Dermatol Venerol; 1985 Jun; (6):4-6. PubMed ID: 3875948
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological aspects of Kaposi's disease].
    Shaposhnikov OK; Karachunova TN
    Vopr Onkol; 1985; 31(12):18-23. PubMed ID: 3002041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of T- and B-lymphocyte functional activity and of the rosette formation phenomenon in Kaposi's angioreticulosis].
    Reznikova LS; Stoianov VB
    Vestn Dermatol Venerol; 1979 Jul; (7):14-7. PubMed ID: 314713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immune response in the course of Kaposi's sarcoma].
    Scalise G; Mura MS; Piersimoni C; Manca S; Cherchi G; Andreoni G
    Boll Ist Sieroter Milan; 1980; 59(6):632-7. PubMed ID: 7236363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional activity of the lymphocytes in patients with Kaposi's sarcoma].
    Korneeva MN; Novokhatskiĭ AS; Grebeniuk VN; Kerimov SG
    Vestn Dermatol Venerol; 1988; (3):32-6. PubMed ID: 3381581
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated Kaposi's sarcoma without lymphocyte abnormalities.
    Ballard HS
    Arch Intern Med; 1985 Mar; 145(3):547. PubMed ID: 3872109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The immune status of patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
    Faradzhev ZG; Derevnina NA; Ivshina AV
    Vestn Dermatol Venerol; 1990; (1):16-20. PubMed ID: 2327165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological and immunological features of primary Kaposi's sarcoma: evaluation before and after chemotherapy.
    Brambilla L; Boneschi V; Pigatto PD; Finzi AF; Marinig C; Renoldi P; Fiorini GF
    Acta Derm Venereol; 1987; 67(3):211-7. PubMed ID: 2442933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic and immunogenetic studies in Kaposi's sarcoma].
    Kadagidze ZG; Kalamkarian AA; Kerimov SG; Derevnina NA; Mazina NM
    Vestn Dermatol Venerol; 1987; (11):15-20. PubMed ID: 3501921
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kaposi sarcoma and Hodgkin disease].
    Pujol Marco C; Alegre de Miguel V; Camps Herrero C; Febrer Bosch I; Oliver Martínez V; Guillén Barona C; Fortea Baixauli JM
    An Med Interna; 1989 May; 6(5):263-5. PubMed ID: 2491541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-cytomegalovirus antibodies in Kaposi's sarcoma].
    Scalise G; Mura MS; Cottoni F; Piersimoni C; Cerimele D; Andreoni G
    Boll Ist Sieroter Milan; 1983 Sep; 62(4):355-61. PubMed ID: 6318781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kaposi's sarcoma].
    Castillo M
    Bol Asoc Med P R; 1983 Jun; 75(6):255-7. PubMed ID: 6577870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disordered cell-receptor metabolism (R-proteins) and the immunity indices in patients with lymphoproliferative diseases of the skin and Kaposi's sarcoma].
    Faradzhev ZG; Samsonov VA; Bukhova VP
    Vestn Dermatol Venerol; 1990; (10):17-20. PubMed ID: 2177582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunology of CD4-negative skin hematosarcomas].
    Sholokhova EN; Probatova NA; Sigidina MIa; Tupitsyn NN; Korotkova OV
    Vestn Dermatol Venerol; 1989; (1):20-6. PubMed ID: 2785738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cytotoxic effect of the thrombocytes from patients with mycosis fungoides and Kaposi's sarcoma].
    Faradzhev ZG; Bolvacheva AV; Bykovskaia SN
    Vestn Dermatol Venerol; 1990; (11):34-6. PubMed ID: 2288150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classical form of Kaposi sarcoma: immunology and interferon therapy].
    Thiele B; Schuff-Werner P; Rahlf G; Mahrle G; Ippen H
    Hautarzt; 1984 Jul; 35(7):349-53. PubMed ID: 6206024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistological study of factor VIII related antigen and Kaposi's sarcoma using polyclonal and monoclonal antibodies.
    Millard PR; Heryet AR
    J Pathol; 1985 May; 146(1):31-8. PubMed ID: 3925107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-immunological characteristics of lymphosarcoma].
    Cheredeev AN; Zimin IuI; Kirzon SS; Kruglova GV; Bragina EG
    Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):19-25. PubMed ID: 6969398
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-cytomegalovirus antibodies and Kaposi's sarcoma].
    Veraldi S; Ferrante P; Barbi M; Mancuso R; Brambilla L; Marini D
    G Ital Dermatol Venereol; 1988 Mar; 123(3):75-7. PubMed ID: 2842256
    [No Abstract]   [Full Text] [Related]  

  • 20. Kaposi's sarcoma and lymphoid neoplasia in the same lesion.
    Pizarro A; Baron JM
    Arch Pathol Lab Med; 1992 Aug; 116(8):812-3. PubMed ID: 1497458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.